Skingel

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Skingel

Property Description
Active ingredient Zinc Oxide
Form Gel (Hydrogel)
Pharmacological class Topical Astringent and Skin Protectant
General purpose Protection against irritation; skin soothing
Route of Administration Topical

Classification and Identity: What Type of Medicine is Skingel?

Skingel is defined as a specialized dermatological preparation intended exclusively for topical administration to the skin's surface. Its therapeutic role is formally classified as a Topical Astringent and Skin Protectant, establishing its primary function as a surface-level barrier agent. This classification confirms Skingel is a non-systemic product; its action is localized entirely on the epidermis, meaning its components do not enter the bloodstream. Zinc Oxide preparations are classified as skin protectants and topical astringents. This means the product works by forming a physical shield on the skin and gently helps to dry surface moisture.


Composition and Physical Form: What is Skingel Made Of?

The therapeutic efficacy of Skingel is derived from its single active ingredient, Zinc Oxide (INN), an inorganic compound utilized for its protective and mild astringent properties. Skingel is specifically formulated as a Gel (Hydrogel), which is a key distinguishing feature compared to traditional, denser Zinc Oxide ointments or pastes. This hydrogel structure is a vehicle designed to facilitate easier, non-occlusive application over affected skin. The gel base and accompanying excipients, such as Glycerin and Propylene Glycol, support the primary ingredient and impart humectant properties. Zinc Oxide, in varying topical forms, is recognized for its protective function against external irritants. Therefore, the product's primary action is rooted in physically isolating the skin from damage.


General Purpose of the Active Ingredient

The general purpose of Skingel is to shield the epidermis and alleviate irritation by promoting a physical separation between vulnerable tissue and external factors. As a Topical Astringent, the Zinc Oxide compound creates a protective barrier on the affected area, minimizing continued exposure to moisture and friction—a typical use scenario might involve minor skin folds irritation or areas susceptible to chafing. This function, supported by the mild drying and soothing action, helps the skin recover from superficial damage.

Regulatory References

  1. PubMed ID 26053308

What side effects are possible with Skingel?

Possible Side Effects and Safety Information

The official safety profile for Skingel (topical Zinc Oxide) is based on its classification as a non-systemic skin protectant, meaning its action is confined to the application site. Regulatory information primarily focuses on localized skin responses and constraints on proper external use.


Documented Safety Profile

Category Regulatory Statement
Adverse Reaction Scope Adverse effects are consistently documented within the Skin and Subcutaneous Tissue Disorders system.
Frequency Classification The frequency of reactions is typically not classified in the official regulatory monographs for this type of over-the-counter (OTC) product.
Serious Adverse Reactions Clinically significant reactions are limited to signs of severe allergic reactions or hypersensitivity at the application site.
Population Safety Notes Due to negligible systemic absorption, no specific constraints are typically noted for renal or hepatic impairment. Some official documents list it under Pregnancy Category C, advising professional consultation for use.

Regulatory Safety Restrictions

Official labels detail high-level constraints and specific usage limitations:

  • External Use Constraint: The preparation is strictly for external use only, and contact with the eyes must be avoided.
  • Application Site: The product should not be applied over large areas of the body or on broken skin.
  • Duration Constraint: Use must be discontinued if the condition worsens or if symptoms persist longer than 7 days or clear up and then reoccur shortly thereafter.

The regulatory documentation structures the safety profile around these constraints, indicating that the principal risks are related to localized reactions or improper application.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Skingel, a topical zinc oxide preparation, distinguishes sharply between excessive surface use and accidental ingestion. Skingel is classified as a non-systemic agent, meaning its components are not significantly absorbed into the bloodstream when applied as directed.

Overdose following topical over-application may result in localized skin manifestations such as temporary mild dryness, localized irritation, or redness. These effects are transient and generally do not require urgent medical intervention.


Required Emergency Action

The primary serious risk recognized in regulatory documents is related to accidental oral ingestion. If a large amount of Skingel is accidentally swallowed, immediate medical attention must be sought.

Exposure Context Required Immediate Action (as mandated by regulators)
Accidental Oral Ingestion Seek immediate medical attention and contact a Poison Control Center.

Accidental ingestion carries the risk of systemic poisoning, which may manifest as gastrointestinal distress, including nausea, vomiting, or abdominal pain. In such cases, management is officially limited to symptomatic and supportive treatment. Regulatory sources confirm that no specific antidote is known for systemic zinc oxide toxicity. Medical observation or hospital monitoring may be required following accidental systemic exposure, particularly in the pediatric population.

Therapeutic Uses of Skingel

What Skingel Treats: Main Uses and Benefits

Skingel is applied across domains where additional symptomatic support is needed for skin irritation related to physical discomfort. This primarily involves conditions where the skin may be compromised by external factors like moisture and friction, such as diaper dermatitis in infants and adults, chafing, and the discomfort of minor burns and scrapes. The product is used for managing chafed skin and helps address symptom clusters that may become intense or disruptive. The medication is commonly used to help with managing these acute symptomatic episodes, particularly when symptoms cluster into patterns characterized by surface redness, soreness, or weeping manifestations (e.g., from poison ivy or mild contact dermatitis). It may assist with easing symptoms related to physical discomfort, contributing to reducing the overall symptom load during periods of heightened symptoms.

“The product is relevant for easing symptoms that interfere with daily comfort, contributing to improved day-to-day comfort during symptomatic periods.”


Quick Fact: Supportive Symptom Management for Superficial Skin Irritation

The product is relevant in contexts marked by increased discomfort or tension, such as used in situations involving certain distressing symptoms related to sensitive skin and providing support for minor, non-severe skin trauma.

Regulatory References

  1. NIH DailyMed listing for Zinc Oxide

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Skingel — Official Regulatory Information

Eligibility Scope

Populations for whom use is allowed (as stated in label): Adults, Children, and Infants.
Populations for whom use is contraindicated: Patients with a known hypersensitivity to Zinc Oxide or any product excipient; Use as the primary treatment for fungal or bacterial infections; Use on large surface wounds or severe burns.
Age-related eligibility rules: Use is established across the entire pediatric population. Some regulatory documents note insufficient data on use in geriatric patients.
Pregnancy and lactation eligibility status: No absolute contraindication is documented. Regulatory guidance advises individuals to consult a healthcare professional before use during pregnancy or breastfeeding.
Eligibility-related restrictions: Conditional use is required on broken skin, large sores, or superinfected lesions at the application site.

Eligibility Classifications (High-Level)

Eligibility severity classification (as defined in official documents): Absolute Contraindication (Hypersensitivity), Established Use (Adults/Pediatrics), Conditional Use (Pregnancy/Broken Skin).

Resulting Eligibility Structure

Official eligibility statements:

  • Contraindicated in patients with known hypersensitivity.
  • Not for use in treating active fungal or bacterial infections.
  • Use is established across the adult and pediatric age ranges.

Connection to the overall eligibility profile (2–4 sentences): The official regulatory profile for Skingel defines non-eligibility through absolute contraindications tied to local factors: ingredient allergy and the severity of the skin injury, prohibiting use on severe burns or to treat established infections. Use is established for both adult and pediatric populations, while restrictions concerning internal organ function (renal or hepatic impairment) are absent due to the negligible systemic absorption of this topical medicine.

What should I know about interactions with other medicines?

Skingel Interactions with other medicines and products

The official interaction profile for Skingel, which contains topical Zinc Oxide, is defined by its classification as a non-systemic Topical Astringent and Skin Protectant. As such, the product is intended for localized action on the skin's surface, with minimal to negligible systemic absorption of the active ingredient.

Interaction Category Official Regulatory Finding
Systemic Drug-Drug Interactions None documented. Official government labels do not list any co-administered medicinal products that alter the systemic exposure of Skingel or are affected by Skingel. The non-systemic route precludes documented pharmacokinetic or pharmacodynamic interactions.
Contraindications or Restrictions None documented. No formal prohibitions, timing separation rules, or restrictions regarding co-administration with other medicinal products, foods, alcohol, or supplements are noted in official labeling.
Procedural Constraint X-ray pictures may be masked. The active ingredient, Zinc Oxide, is radiopaque. Its presence on the skin may interfere with or mask X-ray pictures when applied to the specific area being examined, a documented physical interference constraint.

Connection to the overall interaction profile:

Regulatory documents characterize the Skingel interaction profile by the absence of systemic drug interactions, reflecting its localized function. No specific medicinal products require co-administration restrictions or dose-timing rules. The only documented constraint is a non-systemic physical interference that requires consideration during specific medical diagnostic procedures.

Mechanism of Action

Physical Isolation and Superficial Astringency

The mechanism of Skingel is primarily defined by the physical shielding provided by its active component, Zinc Oxide, which adheres to the stratum corneum. The compound forms an insoluble, hydrophobic barrier that physically isolates the underlying tissue from external factors like moisture and friction. This action limits the contact between irritants and the tissue, thereby reducing the mechanical stimulation of superficial afferent nerve endings. Concurrently, a mild astringency occurs through the non-specific precipitation of surface proteins, which assists in tissue firming and regulating surface fluid balance.


Local Anti-Phlogistic and Epithelial Modulatory Action

The secondary action involves the local release of bioactive zinc ions ( Zn^2+) into the epidermis. These ions act as cofactors and modulators within cellular systems, downregulating the local release of key pro-inflammatory cytokines (e.g., Interleukin-1alpha). This modulation facilitates activity within the Epithelial Barrier Repair Pathway by promoting keratinocyte proliferation and differentiation, which enhances the structural reconstitution of the compromised skin barrier. The product's mode of action is strictly topical and peripheral and is constrained to the upper epidermal layers.

Dosage and Administration Information

How to use Skingel — Official Administration Guidelines

This section outlines the standardized usage procedure for Skingel (Topical Zinc Oxide Gel), focusing on the administration method and schedule. The product is intended exclusively for non-systemic use.


Administration Scope

Category Official Instruction Entity
Route of administration Topical application only (intended for the surface of the skin).
Dosing schedule Apply liberally to cover the affected skin area completely.
Preparation requirements The application site must be cleansed and allowed to dry completely prior to product application.
Age-group rules Usage is generally the same for infants, children, and adults due to the non-systemic nature of the product.

Instruction Classifications (High-Level)

Category Classification
Administration method type Topical (Non-systemic)
Frequency pattern As-needed/Situational (Intermittent, condition-driven frequency). For specific situational uses, application is required with each change.
Use-context constraints OTC, self-care application; Must be preceded by skin cleansing; Potential to stain fabric.

Resulting Procedural Structure

The official usage protocol dictates a standardized approach centered on skin preparation before application. This structured administration ensures that the product is applied at the correct intervals and dosage (liberal coverage) to establish the necessary surface layer. The instructions define a situational use pattern governed by the immediate need for the skin protectant.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Skingel (Topical Zinc Oxide)


Evidence for Use in Mild Diaper Dermatitis

Research has primarily studied the use of topical Zinc Oxide preparations in conditions characterized by fluctuating or episodic manifestations like mild diaper rash. The research base includes numerous randomized controlled trials (RCTs) and several systematic reviews. These studies were mostly conducted in populations of infants and young children. Researchers monitored outcomes linked to irritative states, such as the severity of redness (erythema) and the time required for assessed skin symptoms to change.

The findings describe patterns observed in the studies where applications were used in research exploring short-term symptom changes. Across the systematic reviews, short-term data reported consistent patterns in the measures assessed regarding the protective and barrier role of the preparation in this context. However, the evidence is limited for severe or chronic cases of dermatitis, and long-term effects are not fully established regarding continuous use.


Evidence for Use in Skin Chafing and Minor Irritation

The research that has explored the preparation's role in the context of skin irritation caused by friction includes Observational Studies and limited RCTs. Researchers examined patient-reported outcomes describing perceived discomfort and used visual assessments to monitor changes in skin redness and surface lesions. Research has explored the preparation in both observational settings and limited RCTs.

In the studies, findings help contextualize how patients reported their experience of discomfort, and changes in redness were measured in the localized application area. Studies report changes that were measured during the study period, noting patterns related to surface appearance and immediate symptom patterns.

Evidence quality varies, showing fewer large-scale RCTs specifically evaluating the use of this preparation for generalized chafing. Comparative evidence is lacking to definitively show how this preparation performs against similar barrier products.


Evidence in Special Populations and Long-Term Research

Research involving this preparation has included populations beyond the general adult population. The strongest evidence base, centered on diaper dermatitis, was evaluated in infants and young children. Some research also describes data for older adults requiring skin barrier protection. Data for certain groups, such as those with specific comorbid conditions or pregnancy-related populations, remain insufficient and are not fully established.

The majority of clinical research available for this preparation was studied for short-term or episodic symptom patterns. The follow-up durations were limited, typically lasting days to a few weeks. Consequently, there is limited information for long-term outcomes, and sustained changes over extended periods have not been established by research.

Key Studies & References

  1. Zinc Oxide Ointment Labeling and Uses (OTC Drug Monograph M016) - DailyMed

Frequently Asked Questions (FAQ)

Common questions about Skingel (FAQ)


Q: Can Skingel be used by people with sensitive skin?

Official guidance states that use is contraindicated only in individuals with a known hypersensitivity (an allergic reaction) to the active ingredient, Zinc Oxide, or any of the product’s non-active components. If a known allergy to the active component or any excipient exists, the preparation is generally not recommended.


Q: What are the most common mild side effects reported for Skingel?

The most common documented adverse effects are temporary localized skin reactions. These have been described in official product information to include mild irritation, burning, or stinging at the specific site where the preparation was applied.


Q: Does Skingel cause the skin to feel dry or irritated initially?

The active ingredient is classified as an astringent, which means it can cause a mild drying effect on the skin's surface. Official documents note that the preparation may cause temporary localized skin irritation or a burning sensation upon initial application.


Q: Can Skingel be applied to areas other than the face?

According to official guidance, the product is approved for topical application to affected external skin areas for protection against irritation. Regulatory guidance specifies the product is strictly for external use only on the skin's surface.


Q: Can Skingel be used long-term, or is it only for short periods?

Official guidance states that use must be discontinued if the condition worsens or if symptoms persist longer than 7 days or clear up and then reoccur shortly thereafter. For chronic skin conditions, professional consultation is typically advised.


Q: What ingredients are listed as inactive in Skingel?

The preparation contains the active ingredient Zinc Oxide along with various inactive ingredients, known as excipients. Official labeling provides a complete list of these components, which may include ingredients like Glycerin and Propylene Glycol to maintain the gel form and consistency.


Q: Can Skingel be used alongside a regular moisturizer?

Official documents do not list specific constraints for co-administration with non-medicinal topical products like moisturizers. However, regulatory guidelines require that the preparation must be applied to cleansed and dried skin to ensure proper surface action and adherence.


Q: What is the difference between Skingel and a cream with a similar name?

Skingel is formally defined as a Gel (Hydrogel), which is a key distinguishing feature from traditional, denser Zinc Oxide ointments or pastes. This hydrogel form affects the application, spreadability, and feel on the skin.


Q: Does Skingel work by targeting bacteria or inflammation?

Regulatory documents classify the active ingredient as a skin protectant and astringent. Its action includes forming a physical barrier and modulating the local release of pro-inflammatory cytokines, which are linked to inflammation. It is not formally classified as an antibacterial agent.


Q: Are there any ingredients in other skin products to avoid while using Skingel?

Official regulatory labels do not document any required restrictions or prohibitions for co-administration with other non-medicinal topical products or active cosmetic ingredients.


Q: Can people with certain chronic health conditions use Skingel?

Because the product's action is localized to the skin's surface, its systemic absorption is negligible. For this reason, official regulatory guidance typically notes no need for specific constraints or dose adjustments related to common renal or hepatic impairments (kidney or liver issues).


Q: Is there an age limit for who can use Skingel?

Use is established across the entire pediatric population, including infants, children, and teenagers. However, official documents note that data are insufficient to formally establish use in the geriatric population.


Q: What is the official safety classification of Skingel?

Skingel is officially classified as a Topical Astringent and Skin Protectant. Some official documents list the preparation under Pregnancy Category C, and regulatory guidance advises that individuals seek professional consultation before use during pregnancy.


Q: Can Skingel be applied right after washing the face?

Official administration guidelines require that the application site must be cleansed and allowed to dry completely prior to product application. The official usage procedure suggests avoiding application while the skin is still wet.


Q: Why do some official documents state Skingel is for a specific, narrow condition?

Official documents define the product's general purpose as a skin protectant under broad regulatory guidelines. Specific, narrow conditions, such as diaper dermatitis, are often the primary focus of the clinical studies that support the product's marketing authorization.


Q: What is the likelihood of developing a serious side effect from Skingel?

The frequency of serious reactions is typically not classified in official regulatory documents for this type of over-the-counter product. Clinically significant reactions are limited to signs of severe allergic reactions or hypersensitivity at the application site.


Q: Can Skingel be used on broken or damaged skin?

Official guidance contains a constraint that the product should not be applied over large areas of the body or on broken skin. Contraindications specifically prohibit use on large surface wounds or severe burns due to the risk of irritation.


Q: How quickly should a person expect Skingel to start showing an effect?

Official regulatory labels generally describe the product's action as forming an immediate physical shield upon application. However, regulatory documents do not specify a precise timeframe for the onset of measured therapeutic effects on the underlying condition.


Q: Does using Skingel make the skin more sensitive to sunlight?

Official regulatory documents do not list an increase in skin sensitivity to sunlight (photosensitivity) as a documented side effect or warning associated with the use of this preparation.


Q: Is it normal to feel a tingling sensation after applying Skingel?

The regulatory safety profile notes that localized skin irritation can occur. While tingling is not explicitly listed, this sensation falls under the scope of common, temporary skin reactions documented for this class of topical preparations.


Q: What is meant by 'local irritation' as a side effect of Skingel?

Local irritation is described as an adverse effect confined strictly to the application site. This may manifest as visible signs like redness or sensations such as burning or stinging in the skin area where the preparation was applied.


Q: Does official guidance suggest a specific time of day for Skingel application?

Official regulatory guidance defines the frequency of use as situational and as-needed, without specifying a particular time of day (such as morning or night) for the application. The timing depends on the user's specific need and routine.


Q: Does Skingel have any effect on skin pigmentation?

Regulatory safety documents do not list changes to skin pigmentation, such as lightening or darkening of the skin, as a documented side effect associated with this preparation.


Q: What does 'potential for systemic absorption' mean regarding Skingel?

Systemic absorption refers to the active component entering the bloodstream from the application site. Official documents indicate that this product has minimal to negligible systemic absorption because its action is localized entirely to the skin's surface.


Q: Does Skingel contain parabens or sulfates?

The inclusion or exclusion of specific excipients like parabens or sulfates can be determined by consulting the complete list of inactive ingredients provided in the official regulatory product labeling. The full ingredient list can be reviewed to check for these details.

How should Skingel be stored and disposed of?

Storage and Disposal Requirements

Official regulatory guidelines for this type of topical gel mandate specific handling and storage to maintain product quality and safety.

Storage

  • Temperature and Protection: The medication must be stored at controlled room temperature (e.g., 20°C to 25°C) and protected from excess heat and moisture. The product should not be frozen.
  • Container Integrity: Always keep the medication in its original container with the cap or lid tightly closed when not in use.
  • Safety: To prevent accidental ingestion, the medication must be stored securely out of the sight and reach of children and pets.

Disposal

  • Expired or Unused Medicine: Disposal should prioritize public safety and environmental protection. The preferred method is using an authorized medicine take-back program.
  • Household Disposal: If a take-back program is unavailable, mix the gel with an unappealing substance like dirt or used coffee grounds, place the mixture in a sealed bag, and dispose of it in the trash. Do not flush the medication down a toilet or drain unless explicitly instructed to do so.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Skingel found in:

A-Z Index: